Published in Biochem Biophys Res Commun on June 13, 2003
Critical role of PA28gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis. Proc Natl Acad Sci U S A (2007) 1.45
Unique features of hepatitis C virus capsid formation revealed by de novo cell-free assembly. J Virol (2004) 1.10
Involvement of the PA28gamma-dependent pathway in insulin resistance induced by hepatitis C virus core protein. J Virol (2006) 1.08
Self-assembled HCV core virus-like particles targeted and inhibited tumor cell migration and invasion. Nanoscale Res Lett (2013) 0.80
Subcellular forms and biochemical events triggered in human cells by HCV polyprotein expression from a viral vector. Virol J (2008) 0.79
Double acylation for identification of amino-terminal peptides of proteins isolated by polyacrylamide gel electrophoresis. Rapid Commun Mass Spectrom (2007) 1.37
Immune response to synthetic peptides of dengue prM protein. Vaccine (2002) 1.19
Studies on the toxicity of Punica granatum L. (Punicaceae) whole fruit extracts. J Ethnopharmacol (2003) 1.08
The ciliary Evc/Evc2 complex interacts with Smo and controls Hedgehog pathway activity in chondrocytes by regulating Sufu/Gli3 dissociation and Gli3 trafficking in primary cilia. Hum Mol Genet (2012) 1.00
Regional conformational change involving phosphorylation of tau protein at the Thr231, precedes the structural change detected by Alz-50 antibody in Alzheimer's disease. J Alzheimers Dis (2005) 0.98
Beta-propellers: associated functions and their role in human diseases. Curr Med Chem (2003) 0.97
Amino acid changes in the recombinant Dengue 3 Envelope domain III determine its antigenicity and immunogenicity in mice. Virus Res (2006) 0.94
A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice. Virology (2009) 0.93
Expression and processing of hepatitis C virus structural proteins in Pichia pastoris yeast. Biochem Biophys Res Commun (2006) 0.90
Computational proteomics pitfalls and challenges: HavanaBioinfo 2012 workshop report. J Proteomics (2013) 0.89
Towards the definition of a chimpanzee and human conserved CD6 domain 1 epitope recognized by T1 monoclonal antibody. Hybridoma (Larchmt) (2008) 0.89
Advances in DNA immunization against hepatitis C virus infection. Hum Vaccin (2009) 0.87
Inhibition of LPS-responses by synthetic peptides derived from LBP associates with the ability of the peptides to block LBP-LPS interaction. J Endotoxin Res (2003) 0.87
A dengue-2 Envelope fragment inserted within the structure of the P64k meningococcal protein carrier enables a functional immune response against the virus in mice. J Virol Methods (2004) 0.87
Oral subchronic toxicity of a lipid extract from Roystonea regia fruits in mice. Drug Chem Toxicol (2008) 0.85
HCV core protein localizes in the nuclei of nonparenchymal liver cells from chronically HCV-infected patients. Biochem Biophys Res Commun (2005) 0.85
In silico studies of potential phosphoresidues in the human nucleophosmin/B23: its kinases and related biological processes. J Cell Biochem (2012) 0.84
Characterization of the interaction of domain III of the envelope protein of dengue virus with putative receptors from CHO cells. Virus Res (2008) 0.83
Six-month toxicity study of oral administration of D-003 in Sprague Dawley rats. Drugs R D (2002) 0.82
Nuclear localization of nucleocapsid-like particles and HCV core protein in hepatocytes of a chronically HCV-infected patient. Biochem Biophys Res Commun (2003) 0.82
Multimeric HCV E2 protein obtained from Pichia pastoris cells induces a strong immune response in mice. Mol Biotechnol (2007) 0.82
Antiatherosclerotic effect of an antibody that binds to extracellular matrix glycosaminoglycans. Arterioscler Thromb Vasc Biol (2012) 0.81
Recombinant in vitro assembled hepatitis C virus core particles induce strong specific immunity enhanced by formulation with an oil-based adjuvant. Biol Res (2009) 0.81
Development and validation of a quantitative ELISA for the measurement of PSA concentration. Clin Chim Acta (2002) 0.80
Hepatitis C virus (HCV) core protein enhances the immunogenicity of a co-delivered DNA vaccine encoding HCV structural antigens in mice. Biotechnol Appl Biochem (2006) 0.80
In vitro assembly of nucleocapsid-like particles from purified recombinant capsid protein of dengue-2 virus. Arch Virol (2009) 0.80
A C-terminal truncated hepatitis C virus core protein variant assembles in vitro into virus-like particles in the absence of structured nucleic acids. Biochem Biophys Res Commun (2005) 0.79
Enhancement of the immune response generated against hepatitis C virus envelope proteins after DNA vaccination with polyprotein-encoding plasmids. Biotechnol Appl Biochem (2002) 0.79
HCV core protein-expressing DNA vaccine induces a strong class I-binding peptide DTH response in mice. Biochem Biophys Res Commun (2004) 0.79
In vitro self-assembled HCV core virus-like particles induce a strong antibody immune response in sheep. Biochem Biophys Res Commun (2002) 0.79
Fighting cancer with plant-expressed pharmaceuticals. Trends Biotechnol (2007) 0.78
Identification and characterization of phage-displayed peptide mimetics of Neisseria meningitidis serogroup B capsular polysaccharide. Int J Med Microbiol (2010) 0.78
Complete definition of immunological correlates of protection and clearance of hepatitis C virus infection: a relevant pending task for vaccine development. Int Rev Immunol (2012) 0.78
HCV core protein modulates the immune response against the HBV surface antigen in mice. Biochem Biophys Res Commun (2003) 0.78
Induction of IgA and sustained deficiency of cell proliferative response in chronic hepatitis C. World J Gastroenterol (2008) 0.78
Preventive effect of D-002, a mixture of long-chain alcohols from beeswax, on the liver damage induced with CCl4 in rats. J Med Food (2007) 0.78
In vitro assembly into virus-like particles is an intrinsic quality of Pichia pastoris derived HCV core protein. Biochem Biophys Res Commun (2004) 0.78
Ratio of HCV structural antigens in protein-based vaccine formulations is critical for functional immune response induction. Biotechnol Appl Biochem (2010) 0.78
Scaling up in vitro transcription synthesis of RNA standards for competitive quantitative RT-PCR: looking for bigger yields. Anal Biochem (2008) 0.77
Integrating bioinformatics tools to handle glycosylation. PLoS Comput Biol (2011) 0.77
Comparison of the cholesterol-lowering effects and toxicity of D-003 and lovastatin in normocholesterolaemic rabbits. Drugs R D (2003) 0.77
Isolation of a novel neutralizing antibody fragment against human vascular endothelial growth factor from a phage-displayed human antibody repertoire using an epitope disturbing strategy. J Biotechnol (2010) 0.77
Fast and novel purification method to obtain the prostate specific antigen (PSA) from human seminal plasma. Prostate (2006) 0.76
A 6-Month Study on the Toxicity of High Doses of Policosanol Orally Administered to Sprague-Dawley Rats. J Med Food (2001) 0.76
Immunization with a recombinant fowlpox virus expressing a hepatitis C virus core-E1 polyprotein variant, protects mice and African green monkeys (Chlorocebus aethiops sabaeus) against challenge with a surrogate vaccinia virus. Biotechnol Appl Biochem (2008) 0.76
A comparative molecular dynamics study of thermophilic and mesophilic β-fructosidase enzymes. J Mol Model (2015) 0.76
Light-chain shuffling results in successful phage display selection of functional prokaryotic-expressed antibody fragments to N-glycolyl GM3 ganglioside. J Immunol Methods (2004) 0.76
Immunization with a DNA vaccine candidate in chronic hepatitis C patients is safe, well tolerated and does not impair immune response induction after anti-hepatitis B vaccination. J Gene Med (2010) 0.76
Nucleic acid binding properties and intermediates of HCV core protein multimerization in Pichia pastoris. Biochem Biophys Res Commun (2004) 0.75
Early interferon-based treatment after detection of persistent hepatitis C virus infection: a critical decision. J Interferon Cytokine Res (2010) 0.75
Correction: The Oncogene PDRG1 Is an Interaction Target of Methionine Adenosyltransferases. PLoS One (2016) 0.75
Production of plantibodies in Nicotiana plants. Methods Mol Biol (2009) 0.75
Structured HCV nucleocapsids composed of P21 core protein assemble primary in the nucleus of Pichia pastoris yeast. Biochem Biophys Res Commun (2003) 0.75
Effect of D-003 on a subconvulsive dose of kainic Acid in rats. Drugs R D (2004) 0.75
Multimerization of peptide antigens for production of stable immunogens in transgenic plants. J Biotechnol (2006) 0.75
Effect of D-003 on isoproterenol-induced myocardial necrosis in rats. J Med Food (2003) 0.75
Toxicology and biodistribution study of CIGB-230, a DNA vaccine against hepatitis C virus. Hum Exp Toxicol (2009) 0.75
A chimeric protein encompassing hepatitis C virus epitopes is able to elicit both humoral and cell-mediated immune responses in mice. Biotechnol Appl Biochem (2014) 0.75
Effects of in utero exposure to D-004, a lipid extract from Roystonea regia fruits, in the male rat: a comparison with finasteride. J Med Food (2011) 0.75
Diversity of senile plaques in Alzheimer's disease as revealed by a new monoclonal antibody that recognizes an internal sequence of the Abeta peptide. Curr Alzheimer Res (2005) 0.75
Effect of D-003, a mixture of very-long-chain aliphatic acids purified from sugarcane wax, on cerebral ischemia in Mongolian gerbils. J Med Food (2005) 0.75
Additives and protein-DNA combinations modulate the humoral immune response elicited by a hepatitis C virus core-encoding plasmid in mice. Mem Inst Oswaldo Cruz (2002) 0.75
Immunization with a DNA vaccine encoding the hepatitis-C-virus structural antigens elicits a specific immune response against the capsid and envelope proteins in rabbits and Macaca irus (crab-eating macaque monkeys). Biotechnol Appl Biochem (2004) 0.75